LYNX1 CAPITAL MANAGEMENT LP purchased 270.6% of their position (639.11K shares) of NEUPHORIA THERAPEUTICS INC. on the open market
Open‑market purchase worth $3.28M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/23/2025ACC: 0000902664-25-004536
10% Owner
Since Oct 2025
+639.11K
Net shares
Net buyer
$3.28M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
639.11K acquired
Non-Derivative Transactions1
Common stock, $0.00001 par value per share
Indirect
Shares
+639.11K
Price / share
$5.14
Trade value
$3.28M
% of position
270.6%
10/21/2025
236.22K→875.33K
Total
Net shares
+639.11K
Net value
$3.28M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.00001 par value per share Indirect | 10/21/2025 | P · Purchase | +639.11K | $5.14 | $3.28M | 270.6% | 236.22K | 875.33K |
| Total | +639.11K | $3.28M | ||||||
Derivative Transactions0
No derivative transactions reported